Pharmacological management of sleep-disordered breathing

J. Hedner, D. Zou

Source: Eur Respir Monogr 2010; 50: 321-339

Journal Issue: Sleep Apnoea out of print

Disease area: Sleep and breathing disorders

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Hedner, D. Zou. Pharmacological management of sleep-disordered breathing. Eur Respir Monogr 2010; 50: 321-339

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Sleep, sleep-disordered breathing and metabolic consequences Source: Eur Respir J 2009; 34: 243-260 Year: 2009
Treatment effects of sleep apnoea: where are we now? Source: Eur Respir Rev 2007; 16: 146-168 Year: 2007
Recommendations for the management of patients with obstructive sleep apnoea and hypertension Source: Eur Respir J 2013; 41: 523-538 Year: 2013
Atypical patterns in portable monitoring for sleep apnoea: features of nocturnal epilepsy? Source: Eur Respir J 2013; 41: 368-375 Year: 2013
Weight-loss treatment for OSA: medical and surgical options Source: Eur Respir Mon 2010; 50: 302-320 Year: 2010
Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives Source: Eur Respir J 2008; 32: 1082-1095 Year: 2008
Sleep apnoea and systemic hypertension Source: Eur Respir Mon 2010; 50: 150-173 Year: 2010
Hormonal replacement therapy in sleep-disordered breathing Source: Annual Congress 2007 - Gender-related aspects in sleep apnoea Year: 2007
Pathophysiology of central sleep apnea Source: Annual Congress 2005 - Central sleep apnoea Year: 2005
Outcomes of OSA and indications for different therapies Source: Eur Respir Mon 2010; 50: 225-243 Year: 2010
Compliance in sleep apnoea therapy: influence of home care support and pressure mode Source: Eur Respir J 2009; 33: 804-811 Year: 2009
Sex differences in obstructive sleep apnoea in an elderly French population Source: Eur Respir J 2011; 37: 1137-1143 Year: 2011
Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea Source: Eur Respir J 2012; 39: 1136-1143 Year: 2012
Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study Source: Eur Respir J 2013; 41: 360-367 Year: 2013
Functional effectiveness of auto-CPAP therapy in COPD patients with obstructive sleep apnea Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications Year: 2016
Obstructive sleep apnoea and its association with gestational hypertension Source: Eur Respir J 2009; 33: 559-565 Year: 2009
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006
Clinical implications of residual sleep apnoea after chronic CPAP therapy Source: Breathe 2011; 7: 289-290 Year: 2011
Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Treatment of obstructive and central sleep apnoea in heart failure: current concepts and perspectives Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives Year: 2005